Neurotech International Valuation
| NTI Stock | 0.07 0 4.55% |
Neurotech International seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Neurotech International from analyzing the firm fundamentals such as Current Valuation of 56.66 M, return on equity of -0.64, and Profit Margin of (1.60) % as well as examining its technical indicators and probability of bankruptcy.
Price Book 5.7389 | Enterprise Value 56.7 M | Enterprise Value Ebitda (6.74) | Price Sales 24.5107 | Enterprise Value Revenue 28.9 K |
Overvalued
Today
Please note that Neurotech International's price fluctuation is out of control at this time. Calculation of the real value of Neurotech International is based on 3 months time horizon. Increasing Neurotech International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Neurotech International's intrinsic value may or may not be the same as its current market price of 0.07, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.069 | Real 0.0536 | Hype 0.07 |
The intrinsic value of Neurotech International's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Neurotech International's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Neurotech International helps investors to forecast how Neurotech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neurotech International more accurately as focusing exclusively on Neurotech International's fundamentals will not take into account other important factors: Neurotech International Cash |
|
Neurotech International Total Value Analysis
Neurotech International is now forecasted to have takeover price of 56.66 M with market capitalization of 77.88 M, debt of 314.7 K, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Neurotech International fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
56.66 M | 77.88 M | 314.7 K |
Neurotech International Investor Information
About 34.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Neurotech International had not issued any dividends in recent years. The entity had 8:7 split on the 1st of February 2019. Based on the analysis of Neurotech International's profitability, liquidity, and operating efficiency, Neurotech International is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Neurotech International Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Neurotech International has an asset utilization ratio of 0.0161 percent. This implies that the Company is making USD1.61E-4 for each dollar of assets. An increasing asset utilization means that Neurotech International is more efficient with each dollar of assets it utilizes for everyday operations.Neurotech International Ownership Allocation
Neurotech International maintains a total of 1.03 Billion outstanding shares. Neurotech International holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Neurotech International Profitability Analysis
The company reported the revenue of 1.96 K. Net Loss for the year was (5.07 M) with profit before overhead, payroll, taxes, and interest of 1.19 M.About Neurotech International Valuation
The stock valuation mechanism determines Neurotech International's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Neurotech International based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neurotech International. We calculate exposure to Neurotech International's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Neurotech International's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -5.9 K | 100.6 K |
Additional Tools for Neurotech Stock Analysis
When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.